CIDACIN Antifungal Treatment

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
CIDACIN Antifungal Treatment
Generic name
TOLNAFTATE
Manufacturer
Pedicis Research LLC
Product type
HUMAN OTC DRUG
SPL set ID
bd53a9e3-65c8-4834-8e23-a2a928b83a66
SPL ID
0973a822-e694-feb3-e063-6294a90ab132
Version
6
Effective date
2023-11-05
Source export date
2026-09-28
Source partition
4
Source file
https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/c7ca0b7091cdaeab3f27713a6eef00adcf8fe722383633ddce61531b4c840544/drug-label-0004-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:24:13
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Do not use on children unless directed by a doctor. When using this product avoid eye contact. If eye contact occurs, rinse thoroughly with water for 10-15 minutes. Stop use and ask a doctor if if irritation occurs no improvement is seen 4 weeks. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately. Consult a physician before beginning treatment if pregnant/breast feeding.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.